Gregory Fiore MD
President and Chief Executive Officer
Dr. Fiore is a Co-Founder and is the President and Chief Executive Officer of Sollis Therapeutics. He is an entrepreneur and founder of two successful healthcare consulting firms, Fiore Healthcare Advisors and SSI Strategy. Dr. Fiore was previously the Chief Medical Officer of The Medicines Company, a global, commercial-stage biopharmaceutical company focused on hospital products. Dr. Fiore previously worked as a Strategy Consultant at McKinsey & Company and has held executive roles in several pharmaceutical / biotechnology companies such as Merck, The Medicines Company, and Abbott Laboratories.
Dr. Fiore received medical training at Harvard Medical School’s Brigham and Women’s Hospital and Pulmonary / Critical Care training in the Harvard Medical School Pulmonary and Critical Care Fellowship Program. He received his MD degree and was valedictorian at New York Medical College and received a B.S. degree in Zoology from the University of Rhode Island with honors.
Dr. Fiore serves on several Medical and Business Advisory Committees. He is on the Executive Board of the Institute of Neuromodulation (ION), the Scientific Advisory Board for Advera Health Analytics, the Business Advisory Board for Advanced Clinical Group, the Editorial Advisory Board of Clinical Leader, and the Executive Committee for the Safety of Oral Anticoagulants (SOAR) Registry. He has previously served on the Board of Dubset Media Holdings.
Bryan Jones PhD
Chief Operating Officer
Dr. Jones is a Co-Founder is the Chief Operating Officer of Sollis Therapeutics. He has more than 25 years of experience with Biotech and Specialty Pharmaceutical companies with specific expertise in Business and Product development. Prior to Sollis, he was the Vice President of Operations at Sorrento Therapeutics where he led the development of a neuraxially administered therapy designed to ablate afferent nerves for treatment of chronic pain and neurogenic inflammation. While there, Dr. Jones led the creation of an animal health subsidiary company called ARK Animal Health.
Previously he was Chief Operating Officer at Sherrington Pharmaceuticals and Mt. Cook Pharma as well as Vice President at Kemia and Senior Director of Business Development at Amylin. Earlier in his career, he worked in research at Bristol-Myers Squibb and on products such as Cialis® with ICOS.
Dr. Jones received his B.S. in biology with a concentration in biochemistry from Iowa State University and holds a Ph.D. in genetics from the University of Washington.